Bamidele Adesunloye

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179

Greg Andrew Durm, Salma K. Jabbour, Sandra K. Althouse et al. · Cancer · 2020 · 158 citations · Full text

The Preferred Learning Style among Residents and Faculty Members of an Internal Medicine Residency Program

Bamidele Adesunloye, Oluranti Aladesanmi, Marshaleen Henriques‐Forsythe et al. · Journal of the National Medical Association · 2008 · 86 citations

Nursing, Preferred Learning Style, Education +6

Phase II trial of concurrent chemoradiation with consolidation pembrolizumab in patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.

Greg Andrew Durm, Sandra K. Althouse, Ahad A. Sadiq et al. · Journal of Clinical Oncology · 2018 · 52 citations

Phase Ii Trial, Medicine, Metronomic Therapy +14

Phase <scp>II</scp> trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration‐resistant prostate cancer

Ravi A. Madan, Fatima Karzai, Yang‐Min Ning et al. · British Journal of Urology · 2016 · 28 citations · Full text

Phase 1b/II study of cancer stemness inhibitor napabucasin (BBI-608) in combination with FOLFIRI +/- bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts).

Johanna C. Bendell, Joleen M. Hubbard, Bert H. O’Neil et al. · Journal of Clinical Oncology · 2017 · 14 citations

Pathology, Mcrc Pts, Tumor Biology +16